drugset / Trial / NCT01407380
Study of PWT33597 Mesylate in Subjects With Advanced Malignancies
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1 study evaluating the safety, pharmacokinetics, pharmacodynamics, and clinical effects of orally administered PWT33597 mesylate in subjects with advanced malignancies.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-08
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PWT33597 | Unknown | — | Oral |